Home Supplements How We Rate Blog
5-Hydroxytryptophan

5-HTP

Research reviewed: Up until 03/2026

5-HTP (5-Hydroxytryptophan) is a dietary supplement with 21 published peer-reviewed studies involving 537 participants, researched for Depression & Mood, Sleep Quality, Fibromyalgia & Chronic Pain and 4 more areas.

21
Studies
537
Participants
1990–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Depression & Mood

Moderate
3 studies 1 of 3 positive 103 participants 2 human

Sleep Quality

Moderate
2 studies 2 of 2 positive 100 participants

Fibromyalgia & Chronic Pain

Moderate
2 studies 2 of 2 positive 100 participants

Anxiety & Stress

Weak
1 study 0 of 1 positive 0 participants 0 human

Weight Loss

Moderate
1 study 1 of 1 positive 0 participants

Clinical trials

Moderate
10 studies 1 of 10 positive 234 participants

Systematic reviews

Weak
2 studies 0 of 2 positive 0 participants 0 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

14/21
Randomised
13/21
Double-Blind
14/21
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (1991)
63
Study 2 (2013)
40
Study 3 (2019)
0
Study 1 (2024)
40
Study 2 (2025)
60
Study 1 (1992)
50
Study 2 (1990)
50
Study 1 (2001)
0

Research Timeline

When the studies were published

1
1990
1
1991
2
1992
1
2001
1
2013
1
2019
3
2022
2
2023
5
2024
4
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Depression & Mood

1

To compare the efficacy of 5-HTP with a placebo in treating depression.

1991 63 participants 4 weeks 200 mg/day 5-HTP
Human Study Double-Blind Placebo Positive

Study Type

Double-blind, placebo-controlled

Purpose

To compare the efficacy of 5-HTP with a placebo in treating depression.

Dose

200 mg/day 5-HTP

Participants

63 patients with a diagnosis of depression

Duration

4 weeks

Results

5-HTP produced significantly greater reduction in HAM-D scores compared to placebo. More than 50% of 5-HTP-treated patients showed clinically meaningful improvement vs placebo group.

How They Measured It

Hamilton Depression Rating Scale (HAM-D)

Read full study
2

To compare l-5-hydroxytryptophan (5-HTP) with fluoxetine in patients with first depressive episode.

2013 40 participants 8 weeks 100 mg/day 5-HTP vs 20 mg/day fluoxetine
Human Study RCT Double-Blind Mixed

Study Type

Randomised, double-blind, controlled

Purpose

To compare l-5-hydroxytryptophan (5-HTP) with fluoxetine in patients with first depressive episode.

Dose

100 mg/day 5-HTP vs 20 mg/day fluoxetine

Participants

40 patients with first depressive episode

Duration

8 weeks

Results

Both 5-HTP and fluoxetine produced comparable reductions in HAM-D scores by week 8. 5-HTP showed similar efficacy to fluoxetine with a good tolerability profile.

How They Measured It

Hamilton Rating Scale for Depression (HAM-D), Clinical Global Impression (CGI)

Read full study
3

To evaluate the effects of 5-hydroxytryptophan on distinct types of depression.

2019 ? participants Various 50-600 mg/day 5-HTP
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To evaluate the effects of 5-hydroxytryptophan on distinct types of depression.

Dose

50-600 mg/day 5-HTP

Participants

Meta-analysis of placebo-controlled trials

Duration

Various

Results

5-HTP showed beneficial effects on depression symptoms in placebo-controlled trials, particularly in mild-to-moderate depression. Methodological limitations were noted in older studies. Larger well-designed RCTs needed.

How They Measured It

HAM-D, MADRS, IDS-SR across included RCTs

Read full study

Sleep Quality

1

To assess the impact of 5-HTP supplementation on sleep quality and gut microbiota composition in older adults.

2024 40 participants 8 weeks 100 mg/day 5-HTP
Human Study RCT Placebo Positive

Study Type

Randomised, single-blind, placebo-controlled

Purpose

To assess the impact of 5-HTP supplementation on sleep quality and gut microbiota composition in older adults.

Dose

100 mg/day 5-HTP

Participants

40 older adults with sleep complaints

Duration

8 weeks

Results

5-HTP supplementation significantly improved overall sleep quality scores (PSQI) compared to placebo. Improvements in sleep latency and subjective sleep quality were observed. Gut microbiota diversity also improved.

How They Measured It

Pittsburgh Sleep Quality Index (PSQI), polysomnography, gut microbiota analysis

Read full study
2

To investigate the impact of 5-HTP supplementation on cognitive function and mood in older Singaporean adults.

2025 60 participants 12 weeks 100 mg/day 5-HTP capsules taken 20-30 minutes before bedtime
Human Study RCT Placebo Positive

Study Type

Randomised, single-blind, placebo-controlled

Purpose

To investigate the impact of 5-HTP supplementation on cognitive function and mood in older Singaporean adults.

Dose

100 mg/day 5-HTP capsules taken 20-30 minutes before bedtime

Participants

60 older adults in Singapore aged 60 years and over

Duration

12 weeks

Results

5-HTP significantly improved global cognitive function, mood, and sleep quality compared to control. Significant improvements in MoCA scores, depression, anxiety, and stress subscales of DASS-21 were observed.

How They Measured It

MoCA, DASS-21, Pittsburgh Sleep Quality Index, physical function tests

Read full study

Fibromyalgia & Chronic Pain

1

To evaluate the effects of 5-HTP on symptoms of primary fibromyalgia syndrome including pain, sleep, fatigue, and anxiety.

1992 50 participants 90 days 100 mg three times daily (300 mg/day) of 5-HTP
Human Study Positive

Study Type

Open-label clinical study

Purpose

To evaluate the effects of 5-HTP on symptoms of primary fibromyalgia syndrome including pain, sleep, fatigue, and anxiety.

Dose

100 mg three times daily (300 mg/day) of 5-HTP

Participants

50 patients with primary fibromyalgia

Duration

90 days

Results

All clinical variables (number of tender points, anxiety, pain intensity, quality of sleep, fatigue) showed significant improvement (P<0.001). 5-HTP was well tolerated with no serious adverse effects.

How They Measured It

Tender point count, VAS pain score, Hamilton Anxiety Scale, sleep quality assessment, fatigue rating

Read full study
2

To evaluate 5-HTP vs placebo in the treatment of primary fibromyalgia syndrome.

1990 50 participants 30 days 100 mg three times daily (300 mg/day) of 5-HTP
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate 5-HTP vs placebo in the treatment of primary fibromyalgia syndrome.

Dose

100 mg three times daily (300 mg/day) of 5-HTP

Participants

50 patients with fibromyalgia

Duration

30 days

Results

All clinical parameters were significantly improved by treatment with 5-HTP compared to placebo. Only mild and transient side effects (mainly gastrointestinal) were noted in the 5-HTP group.

How They Measured It

Tender point count, VAS pain, anxiety, fatigue, sleep quality

Read full study

Anxiety & Stress

1

To review the evidence for tryptophan and 5-HTP in treating depression and anxiety disorders.

2001 ? participants Various Various (50-600 mg/day)
Review/Other Positive

Study Type

Systematic review

Purpose

To review the evidence for tryptophan and 5-HTP in treating depression and anxiety disorders.

Dose

Various (50-600 mg/day)

Participants

Systematic review of available clinical trials

Duration

Various

Results

Evidence supports modest but significant anxiolytic and antidepressant effects of 5-HTP. 5-HTP and L-tryptophan are more effective than placebo for depression, with evidence for anxiety reduction also identified.

How They Measured It

Anxiety measures, depression scales across included RCTs

Read full study

Weight Loss

1

To evaluate 5-HTP supplementation on appetite, satiety, and weight loss

1992 ? participants 12 weeks 100 mg 5-HTP, 3 times daily
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled trial

Purpose

To evaluate 5-HTP supplementation on appetite, satiety, and weight loss

Dose

100 mg 5-HTP, 3 times daily

Participants

Obese patients without eating disorders

Duration

12 weeks

Results

5-HTP significantly reduced appetite and caloric intake, leading to modest but significant weight loss compared to placebo.

How They Measured It

Appetite scores, satiety, body weight, BMI

Read full study

Clinical trials

1

To investigate the effects of 5-HTP in the impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: a randomized controlled trial.

2024 ? participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in the impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: a randomized controlled trial.

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

etween gut microbiota composition and sleep quality. 5-Hydroxytryptophan (5-HTP) is known as a precursor of the sleep regulating neurotransmitter and hormone. However, efficacy of 5-HTP supplementation for improving sleep quality in older adults is unclear. Hence, the aim of this study is to assess the impact of 5-HTP supplementation on sleep quality and gut microbiota composition in older adults.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of 5-HTP in the impact of 5-hydroxytryptophan supplementation on cognitive function and mood in singapore older adults: a randomized controlled trial.

2025 30 participants Duration not specified 100 mg
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in the impact of 5-hydroxytryptophan supplementation on cognitive function and mood in singapore older adults: a randomized controlled trial.

Dose

100 mg

Participants

30 participants

Duration

Duration not specified

Results

5-HTP supplementation can enhance cognitive performance and reduce symptoms of depression in Singaporean older adults, potentially through serotonergic modulation. However, given the relatively small sample size ( n = 30) and short-term (12-week) intervention, these findings should be interpreted cautiously, and further long-term studies with a larger sample size are warranted to confirm these pre

How They Measured It

See study for outcome measures

Read full study
3

To investigate the effects of 5-HTP in effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial.

2022 ? participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial.

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Fatigue is highly prevalent among patients with inflammatory bowel disease (IBD), and only limited treatment options are available. Based on the hypothetical link between low serum tryptophan concentrations and fatigue, we determined the effect of 5-hydroxytryptophan supplementation on fatigue in patients with inactive IBD.

How They Measured It

See study for outcome measures

Read full study
4

To investigate the effects of 5-HTP in preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on r

2022 ? participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on r

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

gic neurotransmission may contribute to the non-motor features commonly associated with Parkinson's disease (PD) such as sleep disorders. The 5-hydroxytryptophan (5-HTP) is the intermediate metabolite of L-tryptophan in the production of serotonin and melatonin. The purpose of this study was to compare the effects of 5-HTP to placebo on REM sleep behavior disorder (RBD) status in patients with PD.

How They Measured It

See study for outcome measures

Read full study
5

To investigate the effects of 5-HTP in efficacy and safety of dl-3-n-butylphthalide in the treatment of ischemic poststroke aphasia: a randomized clinical trial.

2024 ? participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in efficacy and safety of dl-3-n-butylphthalide in the treatment of ischemic poststroke aphasia: a randomized clinical trial.

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Poststroke aphasia (PSA) has a high prevalence and requires a long recovery period, severely impairing life and work. Its existing behavioral interventions, principally speech and language therapy, are limited by numerous factors. The aims of this study are to evaluate the efficacy and safety of DL-3-N-butylphthalein (NBP) and explore its mechanism in the treatment of ischemic PSA.

How They Measured It

See study for outcome measures

Read full study
6

To investigate the effects of 5-HTP in [clinical evaluation of the efficacy of innovative spread of a given fatty acid composition enriched by adaptogens].

2023 70 participants 10 days 45 g/day
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in [clinical evaluation of the efficacy of innovative spread of a given fatty acid composition enriched by adaptogens].

Dose

45 g/day

Participants

70 participants

Duration

10 days

Results

. Newly developed spread enriched with 5-hydroxytryptophan, L-theanine, γ-aminobutyric acid was well-tolerated, did not affect the feeling of hunger and satiety, and improved memory and well-being parameters.

How They Measured It

See study for outcome measures

Read full study
7

To investigate the effects of 5-HTP in the effects of 5-htp on body composition: an 8-week preliminary rct.

2023 12 participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in the effects of 5-htp on body composition: an 8-week preliminary rct.

Dose

5-HTP (dose not specified)

Participants

12 participants

Duration

Duration not specified

Results

ed significantly post versus pre in the 5-HTP group ( p  = 0.02) but did not change in the placebo group ( p  = 0.58). Moreover, changes in fat mass were significantly different between the 5-HTP and placebo group ( p  = 0.048). Based on the limited data from this investigation, daily supplementation with 100 mg of 5-HTP may affect body composition.

How They Measured It

See study for outcome measures

Read full study
8

To investigate the effects of 5-HTP in selective influence of hemp fiber ingestion on post-exercise gut permeability: a metabolomics-based analysis.

2025 23 participants Duration not specified 0 g
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in selective influence of hemp fiber ingestion on post-exercise gut permeability: a metabolomics-based analysis.

Dose

0 g

Participants

23 participants

Duration

Duration not specified

Results

Hemp fiber intake during a 2-week supplementation period did not have a significant effect on post-exercise gut permeability in cyclists (2.25 h cycling bout) using urine sugar data. On the contrary, untargeted metabolomics showed that the combination of consuming nutrient-rich hemp fiber bars and exercising for 135 min increased levels of beneficial metabolites, including those derived from the g

How They Measured It

See study for outcome measures

Read full study
9

To investigate the effects of 5-HTP in effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms

2024 69 participants Duration not specified 5-HTP (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of 5-HTP in effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms

Dose

5-HTP (dose not specified)

Participants

69 participants

Duration

Duration not specified

Results

, postbiotics have shown promise in relieving chronic diarrhea.

How They Measured It

See study for outcome measures

Read full study
10

To investigate the effects of 5-HTP in comment on "the impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: a randomized controlled

2024 30 participants Duration not specified 100 mg
Human Study Mixed

Study Type

Clinical study

Purpose

To investigate the effects of 5-HTP in comment on "the impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: a randomized controlled

Dose

100 mg

Participants

30 participants

Duration

Duration not specified

Results

5-HTP supplementation can enhance cognitive performance and reduce symptoms of depression in Singaporean older adults, potentially through serotonergic modulation. However, given the relatively small sample size ( n = 30) and short-term (12-week) intervention, these findings should be interpreted cautiously, and further long-term studies with a larger sample size are warranted to confirm these pre

How They Measured It

See study for outcome measures

Read full study

Systematic reviews

1

To investigate the effects of 5-HTP in early pharmacological interventions for universal prevention of post-traumatic stress disorder (ptsd).

2022 ? participants Duration not specified 5-HTP (dose not specified)
Review/Other Mixed

Study Type

Systematic review

Purpose

To investigate the effects of 5-HTP in early pharmacological interventions for universal prevention of post-traumatic stress disorder (ptsd).

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

terventions should balance efficacy and tolerability, given that not all individuals exposed to a traumatic event will develop PTSD. There are different possible approaches to preventing PTSD; universal prevention is aimed at individuals at risk of developing PTSD on the basis of having been exposed to a traumatic event, irrespective of whether they are showing signs of psychological difficulties.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of 5-HTP in the effect of therapeutic massage combined with conventional therapy in children with functional dyspepsia: a systematic review and meta-analysis.

2025 ? participants Duration not specified 5-HTP (dose not specified)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of 5-HTP in the effect of therapeutic massage combined with conventional therapy in children with functional dyspepsia: a systematic review and meta-analysis.

Dose

5-HTP (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Therapeutic massage has been widely used for functional dyspepsia (FD) in children. Emerging evidence suggests that it serves as an effective complementary therapy for pediatric FD. However, no related systematic reviews have been published to date.

How They Measured It

See study for outcome measures

Read full study

Frequently Asked Questions

Common questions about 5-HTP research

What does the research say about 5-HTP?

There are currently 21 peer-reviewed studies on 5-HTP (5-Hydroxytryptophan), involving 537 total participants. Research covers Depression & Mood, Sleep Quality, Fibromyalgia & Chronic Pain and 4 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for 5-HTP?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (17 human studies), and reported outcomes.

What health goals has 5-HTP been studied for?

5-HTP has been researched for: Depression & Mood, Sleep Quality, Fibromyalgia & Chronic Pain, Anxiety & Stress, Weight Loss, Clinical trials, Systematic reviews. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on 5-HTP based on human trials?

Yes, 17 out of 21 studies are human trials. Human trials carry more weight in our evidence scoring system.